From Constant Pain to Renewed Energy: Pamela’s LDN Success Story with hEDS & MCAS

Pamela from the United States shares her journey with hypermobile Ehlers-Danlos syndrome (hEDS) and mast cell activation syndrome (MCAS), detailing how Low Dose Naltrexone (LDN) transformed her quality of life.She recalls being frequently ill as a child with chronic sore throats, fevers, and unexplained rashes, treated repeatedly with antibiotics, which left her with long-term side effects. In adulthood, she experienced worsening joint pain, migraines, back and neck problems, and multiple orthopedic challenges, especially after childbirth and through menopause.After learning about LDN from Ehlers-Danlos support groups and a physiatrist, Pamela started treatment at 0.5 mg, later increasing to 3 mg. Initial side effects (constipation and nausea) subsided after two weeks, followed by significant improvements in pain levels, energy, and immune function—she hasn’t caught illnesses that previously plagued her.She describes a clear decline when she was off LDN for 11 days, reinforcing its benefits. Pamela now enjoys more stability, less pain, better post-menopause symptoms, and greater day-to-day functionality.Her advice: LDN is worth trying for chronic pain and autoimmune-related conditions, as it may improve both symptoms and general health with minimal side effects for most people.